Tell Us What You Need Collected

Prospective collection · Protocol-specific

Populations / indications

Rheumatoid arthritis, SLE / lupus, Sjögren’s, systemic sclerosis, lupus nephritis, IgA nephropathy, myasthenia gravis, and multiple sclerosis.

Specimen types

Whole blood, PBMC, plasma, serum; synovial fluid when feasible.

Collection structures

Paired pretreatment / on-treatment and flare / recovery collections; longitudinal follow-up.

Clinical data / annotation

Treatment history, disease activity, collection timepoint, and available clinical measurements.

Prospective collection · Protocol-specific

Populations / indications

AML, ALL (B-ALL / T-ALL), APL, myeloid sarcoma, MPAL, MDS, MPN, CML, DLBCL, CLL, multiple myeloma, and solid tumors.

Specimen types

Peripheral blood, bone marrow aspirate, PBMC, plasma, serum, FFPE tissue, fresh / frozen tumor tissue, and matched blood / tissue.

Collection structures

Matched donor sets, fresh collection windows, and pretreatment or on-treatment timepoints.

Clinical data / annotation

Diagnosis, treatment status, pathology details, specimen provenance, and available clinical context.

Prospective collection · Protocol-specific

Populations / indications

COPD, asthma, pulmonary nodules, NSCLC, and other lung cancer populations.

Specimen types

Whole blood, plasma, serum, sputum, and fresh / frozen / FFPE lung tissue when feasible.

Collection structures

Condition-defined cohorts, matched liquid and tissue samples, and protocol-specific collection windows.

Clinical data / annotation

Relevant diagnosis, collection timing, treatment and available pulmonary clinical data.

Prospective collection · Protocol-specific

Populations / indications

NSCLC, colorectal, pancreatic, bladder, and other solid tumors.

Specimen types

Whole blood, plasma, serum, urine, and fresh / frozen / FFPE tumor tissue.

Collection structures

Matched liquid biopsy and tissue; longitudinal treatment timepoints and paired specimens.

Clinical data / annotation

Tumor type, pathology, treatment stage, collection timepoint, and available clinical context.

Prospective collection · Protocol-specific

Populations / indications

Disease-specific and protocol-defined research populations, including remnant collections where appropriate.

Specimen types

Whole blood, plasma, serum, PBMC, urine, sputum, remnant CSF, and synovial fluid where feasible.

Collection structures

Specified volumes, collection intervals, processing windows, and matched biofluid sets.

Clinical data / annotation

Collection and processing details, donor eligibility, and requested clinical / demographic context.

Prospective collection · Protocol-specific

Populations / indications

Prospective healthy donors and protocol-defined control cohorts.

Specimen types

Blood, plasma, serum, PBMC, urine; frozen normal tissue sourcing / collection where feasible.

Collection structures

Matched controls, repeat timepoints, and age- or criteria-defined cohorts.

Clinical data / annotation

Eligibility criteria, de-identified demographics, and relevant collection documentation.

Prospective collection · Protocol-specific

Populations / indications

Diabetes, obesity / metabolic health, and cardiology populations.

Specimen types

Whole blood, plasma, serum, and protocol-defined related specimens.

Collection structures

Defined disease cohorts, baseline and follow-up collections, and longitudinal sampling.

Clinical data / annotation

Disease status, treatment context, timepoint, and available metabolic / cardiology measurements.

Prospective collection · Protocol-specific

Populations / indications

Disease-specific cohorts defined by your study protocol and eligibility criteria.

Specimen types

Paired specimen types and matched collections specified by the research plan.

Collection structures

Pretreatment / on-treatment, flare / recovery, serial treatment timepoints, and custom processing.

Clinical data / annotation

Timepoint tracking, treatment annotation, study-specific documentation, and requested clinical data.